Several mechanisms are involved in CD274 expression improvement on tumor cells, such as the activation of intracellular signaling pathways (MAPK and PI3K-Akt), the enhanced activity of transcription factors (STAT3), and a rising occurrence of inflammatory mediators (interferon-γ and interleukin-6) [90]. The gene discussed is CD274; the disease is neoplasm.